Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone

Stopped early · Phase 3

Conditions studied: Diabetes Mellitus, Type 2

In brief

This study will evaluate the long-term safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM).

Key facts

Study ID

NCT01089790

Run by

Forest Laboratories

People needed

141

Starts

2010-03-01

Last updated by the study team

2011-09-21

Who can join

Age: 18 and older, up to 86. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have successfully completed all required visits of a qualifying Phase 3 core protocol
• Be currently receiving treatment for T2DM as set forth in the qualifying Phase 3 core protocol

You may not qualify if…

• Any condition, disease, disorder or clinically relevant laboratory abnormality which, in the opinion of the investigator, would jeopardize the patient's appropriate participation in this study or obscure the effects of treatment

Where it is running

• Forest Investigative Site 020 — Birmingham, Alabama, United States
• Forest Investigative Site 025 — Muscle Shoals, Alabama, United States
• Forest Investigative Site 059 — Chandler, Arizona, United States
• Forest Investigative Site 113 — Gilbert, Arizona, United States
• Forest Investigative Site 096 — Goodyear, Arizona, United States
• Forest Investigative Site 080 — Peoria, Arizona, United States
• Forest Investigative Site 098 — Phoenix, Arizona, United States
• Forest Investigative Site 133 — Phoenix, Arizona, United States
• Forest Investigative Site 044 — Scottsdale, Arizona, United States
• Forest Investigative Site 087 — Tucson, Arizona, United States
• Forest Investigative Site 061 — Anaheim, California, United States
• Forest Investigative Site 152 — Anaheim, California, United States
• Forest Investigative Site 041 — Chula Vista, California, United States
• Forest Investigative Site 049 — Encinitas, California, United States
• Forest Investigative Site 022 — Greenbrae, California, United States
• Forest Investigative Site 047 — Harbor City, California, United States
• Forest Investigative Site 010 — Huntington Park, California, United States
• Forest Investigative Site 070 — Los Angeles, California, United States
• Forest Investigative Site 111 — Northridge, California, United States
• Forest Investigative Site 031 — Riverside, California, United States
• Forest Investigative Site 091 — Roseville, California, United States
• Forest Investigative Site 140 — Sacramento, California, United States
• Forest Investigative Site 067 — Sacramento, California, United States
• Forest Investigative Site 145 — San Mateo, California, United States
• Forest Investigative Site 064 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.